Skip to main content
Back
Watch Compare

Instil Bio, Inc.

Data quality: 83%
TIL
Nasdaq Manufacturing Chemicals
$8.35
▼ $0.19 (-2.22%)
Mkt Cap: 56.63 M
Price
$8.35
Mkt Cap
56.63 M
Day Range
$8.17 — $8.47
52-Week Range
$5.67 — $42.79
Volume
7,809
Open $8.24
50D / 200D Avg
$8.21
1.70% above
50D / 200D Avg
$16.49
49.36% below

Quick Summary

Key Takeaways

Negative free cash flow of -36.62 M

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-56.62%
Below sector avg (-51.02%)
ROIC-29.34%
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
N/A
Current Ratio34.45
Interest Coverage-13.48

Valuation

PE (TTM)
-0.79
Above sector avg (-1.98)
P/B Ratio0.47
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (44 peers)
Metric Stock Sector Median
P/E -0.8 -2.0
P/B 0.5 5.1
ROE % -56.6 -51.0
Net Margin % — -150.2
Rev Growth 5Y % — 9.3
D/E — 0.3

ETFs Holding This Stock

AVSC logo AVSC Avantis U.S. Small Cap Equity ETF
0.01% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -71.37 M
ROE -56.62% ROA -32.24%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -36.62 M
ROIC -29.34% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 34.45
Interest Coverage -13.48 Asset Turnover N/A
Working Capital 190.57 M Tangible Book Value 120.42 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.79 Forward P/E N/A
P/B Ratio 0.47 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -64.66%
Market Cap 56.63 M Enterprise Value 50.83 M
Per Share
EPS (Diluted TTM) -10.70 Revenue / Share N/A
FCF / Share -5.40 OCF / Share -5.40
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 51.31%
SBC-Adj. FCF -47.77 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — 0.0
Net Income -71.37 M -74.14 M -156.09 M -223.18 M -156.79 M
EPS (Diluted) -10.70 -11.39 -24.00 -1.72 -1.48
Gross Profit — — — — —
Operating Income -78.58 M -73.54 M -159.17 M -226.46 M -155.56 M
EBITDA — — — — —
R&D Expenses — — 39.60 M 141.06 M 107.25 M
SG&A Expenses — — — — —
D&A 534,000.0 3.61 M 4.76 M 5.99 M 2.75 M
Interest Expense 5.83 M 8.99 M 5.21 M 1.88 M —
Income Tax 0.0 — 0.0 -2.07 M 39,000.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 203.52 M 263.57 M 325.63 M 482.13 M 609.98 M
Total Liabilities 89.66 M 94.13 M 99.80 M 118.52 M 54.78 M
Shareholders' Equity 113.87 M 169.44 M 225.83 M 363.61 M 555.20 M
Total Debt — — — — —
Cash & Equivalents 6.64 M 8.81 M 9.20 M 43.72 M 37.59 M
Current Assets 191.43 M 124.47 M 160.76 M 269.38 M 464.02 M
Current Liabilities 4.84 M 7.90 M 10.56 M 32.79 M 41.36 M